MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
16.66
-0.19 (-1.13%)
At close: Apr 28, 2026, 4:00 PM EDT
16.76
+0.10 (0.59%)
After-hours: Apr 28, 2026, 7:33 PM EDT

MLTX Stock Forecast

Stock Price Forecast

The 12 analysts with 12-month price forecasts for MLTX stock have an average target of 27.5, with a low estimate of 5.00 and a high estimate of 70. The average target predicts an increase of 65.07% from the current stock price of 16.66.

Analyst Consensus: Buy
Target Low Average Median High
Price $5.00 $27.5 $25 $70
Change -69.99% +65.07% +50.06% +320.17%
* Price targets were last updated on Mar 30, 2026.

Analyst Ratings

The average analyst rating for MLTX stock from 12 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Nov '25Dec '25Jan '26Feb '26Mar '26Apr '26
Strong Buy 444466
Buy 222333
Hold 221111
Sell 000000
Strong Sell 112222
Total 999101212

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
BTIG
BTIG
Strong Buy
Reiterates
$30
Strong Buy Reiterates $30 +80.07% Mar 30, 2026
Wolfe Research
Wolfe Research
Buy
Upgrades
$12$24
Buy Upgrades $12$24 +44.06% Mar 23, 2026
Rothschild & Co
Rothschild & Co
Strong Buy
Upgrades
$12$40
Strong Buy Upgrades $12$40 +140.10% Mar 19, 2026
Clear Street
Clear Street
Strong Buy
Maintains
$45$70
Strong Buy Maintains $45$70 +320.17% Mar 11, 2026
RBC Capital
RBC Capital
Hold
Maintains
$12$13
Hold Maintains $12$13 -21.97% Mar 2, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
20.71M
EPS This Year
-3.74
from -3.53
EPS Next Year
-3.71
from -3.74
Fiscal Year FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
------20.71M
Revenue Growth
-------
EPS
-8.21-1.70-0.73-1.89-3.53-3.74-3.71
EPS Growth
-------
Forward PE
-------
No. Analysts -----1716
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20262027202820292030203120322033
High n/a 43.6M
Avg n/a 20.7M
Low n/a n/a

Revenue Growth

Revenue Growth 20262027202820292030203120322033
High - -
Avg - -
Low - -

EPS Forecast

EPS 20262027202820292030203120322033
High -2.79 -2.73
Avg -3.74 -3.71
Low -4.23 -5.10

EPS Growth

EPS Growth 20262027202820292030203120322033
High - -
Avg - -
Low - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.